Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation

2014 ◽  
Vol 104 (1) ◽  
pp. 92-93 ◽  
Author(s):  
Klaudija Bijuklic ◽  
Lorenz Hansen ◽  
Julian Witt ◽  
Joachim Schofer
2017 ◽  
Vol 26 (4) ◽  
pp. e19-e21 ◽  
Author(s):  
Cheng He ◽  
Gregory Scalia ◽  
Darren L. Walters ◽  
Andrew Clarke

2020 ◽  
Vol 7 (12) ◽  
pp. 201838
Author(s):  
Romina Plitman Mayo ◽  
Halit Yaakobovich ◽  
Ariel Finkelstein ◽  
Shawn C. Shadden ◽  
Gil Marom

Leaflet thrombosis has been suggested as the reason for the reduced leaflet motion in cases of hypoattenuated leaflet thickening of bioprosthetic aortic valves. This work aimed to estimate the risk of leaflet thrombosis in two post-valve-in-valve (ViV) configurations, using five different numerical approaches. Realistic ViV configurations were calculated by modelling the deployments of the latest version of transcatheter aortic valve devices (Medtronic Evolut PRO, Edwards SAPIEN 3) in the surgical Sorin Mitroflow. Computational fluid dynamics simulations of blood flow followed the dry models. Lagrangian and Eulerian measures of near-wall stagnation were implemented by particle and concentration tracking, respectively, to estimate the thrombogenicity and to predict the risk locations. Most of the numerical approaches indicate a higher leaflet thrombosis risk in the Edwards SAPIEN 3 device because of its intra-annular implantation. The Eulerian approaches estimated high-risk locations in agreement with the wall sheer stress (WSS) separation points. On the other hand, the Lagrangian approaches predicted high-risk locations at the proximal regions of the leaflets matching the low WSS magnitude regions of both transcatheter aortic valve implantation models and reported clinical and experimental data. The proposed methods can help optimizing future designs of transcatheter aortic valves with minimal thrombotic risks.


2018 ◽  
Vol 27 (3) ◽  
pp. e23-e24
Author(s):  
Javier Gualis ◽  
Rodrigo Estévez-Loureiro ◽  
David Alonso ◽  
Jose Manuel Martínez-Comendador ◽  
Elio Martín ◽  
...  

Author(s):  
Riccardo Cocchieri ◽  
Ezra Y. Koh ◽  
Bas A. De Mol

We report a case of transapical mitral valve-in-valve implantation for a deteriorated bioprosthesis using the SAPIEN 3. Our patient, a 79-year-old man, with a history of mitral valve replacement 10 years before, presented with acute dyspnea due to mitral valve dysfunction. He was successfully treated with transapical implantation and had an uneventful recovery. Our case demonstrates the feasibility of using SAPIEN 3 in treating degenerated bioprosthetic mitral valves.


2016 ◽  
Vol 31 (9) ◽  
pp. 575-577 ◽  
Author(s):  
Javier Gualis ◽  
Rodrigo Estévez-Loureiro ◽  
David Alonso ◽  
Jose Manuel Martínez-Comendador ◽  
Elio Martín ◽  
...  

Author(s):  
Anupama Shivaraju ◽  
Jonathan Michel ◽  
Antonio H. Frangieh ◽  
Ilka Ott ◽  
Christian Thilo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document